Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.

MLA

Ligia Petrica, Ligia, et al. “Glycated Peptides Are Associated with the Variability of Endothelial Dysfunction in the Cerebral Vessels and the Kidney in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.” Journal of Diabetes & Its Complications, vol. 29, no. 2, Mar. 2015, pp. 230–37. EBSCOhost, https://doi.org/10.1016/j.jdiacomp.2014.11.014.

APA

Ligia Petrica, L., Vlad, A., Gluhovschi, G., Gadalean, F., Dumitrascu, V., Vlad, D., Popescu, R., Velciov, S., Gluhovschi, C., Bob, F., Ursoniu, S., Petrica, M., & Jianu, D. C. (2015). Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study. Journal of Diabetes & Its Complications, 29(2), 230–237. https://doi.org/10.1016/j.jdiacomp.2014.11.014

Chicago

Ligia Petrica, Ligia, Adrian Vlad, Gheorghe Gluhovschi, Florica Gadalean, Victor Dumitrascu, Daliborca Vlad, Roxana Popescu, et al. 2015. “Glycated Peptides Are Associated with the Variability of Endothelial Dysfunction in the Cerebral Vessels and the Kidney in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study.” Journal of Diabetes & Its Complications 29 (2): 230–37. doi:10.1016/j.jdiacomp.2014.11.014.